Bristol-Myers Squibb (BMY) Tops Q1 EPS by 7c, Beats on Revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to Bristol-Myers Squibb (BMY) Tops Q1 EPS by 7c, Beats on Revenue

Bristol-Myers Squibb Co. (BMY) PT Lowered to $53 at Deutsche Bank

April 29, 2024 5:27 AM EDT

Deutsche Bank analyst James Shin lowered the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $53.00 (from $55.00) while maintaining a Hold rating.

The analyst comments "We get it - BMY's cost cut is poor optics given low visibility for late-decade revenues and... More

Bristol-Myers Squibb (BMY) stock slips despite earnings beat

April 25, 2024 7:09 AM EDT

(Updated - April 25, 2024 7:26 AM EDT)

Bristol-Myers Squibb (NYSE: BMY) reported better-than-expected earnings and revenue for the first quarter of 2024.

Still, BMY stock fell by 1.7% in premarket trading.

The company reported a loss per share of $4.40, compared to the estimated loss per share of $4.47. Revenue for the quarter reached $11.9 billion, exceeding the consensus... More